PSMG2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.462800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.320800E-01
Normal-vs-Stage2
9.551400E-01
Normal-vs-Stage3
4.088200E-01
Normal-vs-Stage4
4.438600E-01
Stage1-vs-Stage2
1.092590E-01
Stage1-vs-Stage3
9.254000E-01
Stage1-vs-Stage4
5.374600E-01
Stage2-vs-Stage3
2.292200E-01
Stage2-vs-Stage4
4.580000E-01
Stage3-vs-Stage4
7.018400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.367400E-01
Normal-vs-AfricanAmerican
9.999400E-01
Normal-vs-Asian
8.918000E-01
Caucasian-vs-AfricanAmerican
9.112400E-01
Caucasian-vs-Asian
6.104400E-01
AfricanAmerican-vs-Asian
8.775600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.468800E-01
Normal-vs-Female
9.341400E-01
Male-vs-Female
9.894800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.273800E-01
Normal-vs-Age(41-60Yrs)
6.613600E-01
Normal-vs-Age(61-80Yrs)
7.523600E-01
Normal-vs-Age(81-100Yrs)
8.017200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.500400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.123000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.095400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.244260E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.545600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.014800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.467800E-01
Normal-vs-Daily Drinker
8.920200E-01
Normal-vs-Weekly Drinker
8.914000E-01
Normal-vs-Occasional Drinker
6.819800E-01
Normal-vs-Social Drinker
8.603000E-01
Non Drinker-vs-Daily Drinker
6.039600E-01
Non Drinker-vs-Weekly Drinker
2.741400E-01
Non Drinker-vs-Occasional Drinker
8.034000E-01
Non Drinker-vs-Social Drinker
2.340800E-01
Daily Drinker-vs-Weekly Drinker
6.527000E-01
Daily Drinker-vs-Occasional Drinker
7.826400E-01
Daily Drinker-vs-Social Drinker
6.110800E-01
Weekly Drinker-vs-Occasional Drinker
3.623400E-01
Weekly Drinker-vs-Social Drinker
9.623200E-01
Occasional Drinker-vs-Social Drinker
3.132400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.674200E-01
Normal-vs-Grade 2
8.702600E-01
Normal-vs-Grade 3
5.130400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.756100E-02
Grade 1-vs-Grade 3
2.392100E-02
Grade 1-vs-Grade 4
9.674200E-01
Grade 2-vs-Grade 3
2.845800E-01
Grade 2-vs-Grade 4
8.702600E-01
Grade 3-vs-Grade 4
5.130400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.782000E-01
Normal-vs-NonDiabetic
9.488200E-01
Diabetic-vs-NonDiabetic
1.234560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.696400E-01
Normal-vs-NoPancreatitis
9.315600E-01
Pancreatitis-vs-NoPancreatitis
8.122800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.349400E-01
Normal-vs-N1
9.981200E-01
N0-vs-N1
7.562200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.187200E-01
Normal-vs-TP53-NonMutant
7.128200E-01
TP53-Mutant-vs-TP53-NonMutant
6.979400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
